GT
QGENF

Glenmede Trust’s QIAGEN NV QGENF Stock Holding History

Glenmede Trust’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-31,953
Closed -$894K – 2885
2016
Q4 		$894K Buy
31,953
+162
+0.5% +$4.53K ﹤0.01% 776
2016
Q3 		$871K Sell
31,791
-1,217
-4% -$33.3K ﹤0.01% 778
2016
Q2 		$719K Sell
33,008
-1,793
-5% -$39.1K ﹤0.01% 818
2016
Q1 		$777K Buy
34,801
+2,270
+7% +$50.7K 0.01% 794
2015
Q4 		$899K Sell
32,531
-4,071
-11% -$113K 0.01% 781
2015
Q3 		$944K Sell
36,602
-1,430
-4% -$36.9K 0.01% 744
2015
Q2 		$942K Sell
38,032
-3,420
-8% -$84.7K 0.01% 757
2015
Q1 		$1.04M Sell
41,452
-2,480
-6% -$62.5K 0.01% 761
2014
Q4 		$1.03M Buy
43,932
+1,600
+4% +$37.5K 0.01% 707
2014
Q3 		$963K Sell
42,332
-750
-2% -$17.1K 0.01% 710
2014
Q2 		$1.05M Hold
43,082
– – 0.01% 686
2014
Q1 		$907K Buy
43,082
+18,340
+74% +$386K 0.01% 716
2013
Q4 		$588K Buy
24,742
+4,980
+25% +$118K 0.01% 802
2013
Q3 		$422K Buy
19,762
+3,400
+21% +$72.6K 0.01% 866
2013
Q2 		$324K Buy
+16,362
New +$324K ﹤0.01% 922

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Glenmede Trust's QGENF Position: Q1 2017 in Review

Glenmede Trust sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 31,953 shares — an estimated $894K sold.

Glenmede Trust first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $1.05M in Q2 2014. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Glenmede Trust reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Glenmede Trust sold 31,953 QIAGEN NV shares in Q1 2017, an estimated $894K.
  • Glenmede Trust first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Glenmede Trust's QIAGEN NV position peaked at $1.05M in Q2 2014.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.